Concomitant Detection of HER2 Protein and Gene Alterations by Immunohistochemistry (IHC) and Silver Enhanced In Situ Hybridization (SISH) Identifies HER2 Positive Breast Cancer with and without Gene Amplification
Figure 4
Stratification of IHC score 0/1+ tumors and amplification status by SISH to overall survival.
There is a tendency to shorter overall survival in HER2 amplified IHC score 0/1+ cases (Kaplan Meier curves).